相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The reactome pathway knowledgebase 2022
Marc Gillespie et al.
NUCLEIC ACIDS RESEARCH (2022)
Lower Fracture Rates in Patients Treated with Radium-223, Abiraterone or Enzalutamide, When Given Concurrently with Bone Health Agents: A Real-World Analysis
Janson Trieu et al.
CLINICAL GENITOURINARY CANCER (2022)
Apalutamide, Darolutamide and Enzalutamide for Nonmetastatic Castration-Resistant Prostate Cancer (nmCRPC): A Critical Review
Carlo Cattrini et al.
CANCERS (2022)
Decreased fracture rate by mandating bone protecting agents in the EORTC 1333/PEACEIII trial combining Ra223 with enzalutamide versus enzalutamide alone: An updated safety analysis.
Silke Gillessen et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Radium-223 plus Enzalutamide Versus Enzalutamide in Metastatic Castration-Refractory Prostate Cancer: Final Safety and Efficacy Results
Benjamin L. Maughan et al.
ONCOLOGIST (2021)
Radium-223 in combination with enzalutamide in metastatic castration-resistant prostate cancer: a multi-centre, phase II open-label study
Raymond S. McDermott et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2021)
Prospective Evaluation of Bone Metabolic Markers as Surrogate Markers of Response to Radium-223 Therapy in Metastatic Castration-resistant Prostate Cancer
Neeraj Agarwal et al.
CLINICAL CANCER RESEARCH (2020)
Open Label Phase II Study of Enzalutamide With Concurrent Administration of Radium 223 Dichloride in Patients With Castration-Resistant Prostate Cancer
Neal D. Shore et al.
CLINICAL GENITOURINARY CANCER (2020)
Concurrent or layered treatment with radium-223 and enzalutamide or abiraterone/prednisone: real-world clinical outcomes in patients with metastatic castration-resistant prostate cancer
Neal Shore et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2020)
Five-year Survival Prediction and Safety Outcomes with Enzalutamide in Men with Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer from the PREVAIL Trial
Andrew J. Armstrong et al.
EUROPEAN UROLOGY (2020)
The effects of prednisone, abiraterone acetate and radium-223 dichloride on bone in the intratibial LNCaP prostate cancer model
Mari Suominen et al.
CANCER RESEARCH (2020)
Targeting DNA Damage Response in Prostate and Breast Cancer
Antje M. Wengner et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Enzalutamide therapy for advanced prostate cancer: efficacy, resistance and beyond
Simon Linder et al.
ENDOCRINE-RELATED CANCER (2019)
Decreased fracture rate by mandating bone-protecting agents in the EORTC 1333/PEACE III trial comparing enzalutamide and Ra223 versus enzalutamide alone: An interim safety analysis.
Bertrand F. Tombal et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer
Andrew J. Armstrong et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Radiosensitization by enzalutamide for human prostate cancer is mediated through the DNA damage repair pathway
Konjeti R. Sekhar et al.
PLOS ONE (2019)
Identification of a Radiosensitivity Molecular Signature Induced by Enzalutamide in Hormone-sensitive and Hormone-resistant Prostate Cancer Cells
Maryam Ghashghaei et al.
SCIENTIFIC REPORTS (2019)
The Mode-of-Action of Targeted Alpha Therapy Radium-223 as an Enabler for Novel Combinations to Treat Patients with Bone Metastasis
Mari Suominen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Enhanced radiosensitization of enzalutamide via schedule dependent administration to androgen-sensitive prostate cancer cells
Maryam Ghashghaei et al.
PROSTATE (2018)
Exploring the Role of Enzalutamide in Combination with Radiation Therapy: An In Vitro Study
Luca Triggiani et al.
ANTICANCER RESEARCH (2018)
Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer
Maha Hussain et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Radium-223 Inhibits Osseous Prostate Cancer Growth by Dual Targeting of Cancer Cells and Bone Microenvironment in Mouse Models
Mari I. Suominen et al.
CLINICAL CANCER RESEARCH (2017)
Enzalutamide Reduces the Bone Mass in the Axial But Not the Appendicular Skeleton in Male Mice
Jianyao Wu et al.
ENDOCRINOLOGY (2016)
The PREVAIL Study: Primary Outcomes by Site and Extent of Baseline Disease for Enzalutamide-treated Men with Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer
Christopher P. Evans et al.
EUROPEAN UROLOGY (2016)
The safety and efficacy of radium-223 dichloride for the treatment of advanced prostate cancer
James M. Wilson et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2016)
Androgen Receptor Upregulation Mediates Radioresistance after Ionizing Radiation
Daniel E. Spratt et al.
CANCER RESEARCH (2015)
Molecular Characterization of Enzalutamide-treated Bone Metastatic Castration-resistant Prostate Cancer
Eleni Efstathiou et al.
EUROPEAN UROLOGY (2015)
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Yang Liao et al.
BIOINFORMATICS (2014)
Standardized Nomenclature, Symbols, and Units for Bone Histomorphometry: A 2012 Update of the Report of the ASBMR Histomorphometry Nomenclature Committee
David W. Dempster et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
C. Parker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Androgen Receptor Signaling Regulates DNA Repair in Prostate Cancers
William R. Polkinghorn et al.
CANCER DISCOVERY (2013)
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
Howard I. Scher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Molecular signatures database (MSigDB) 3.0
Arthur Liberzon et al.
BIOINFORMATICS (2011)
BLM-DNA2-RPA-MRN and EXO1-BLM-RPA-MRN constitute two DNA end resection machineries for human DNA break repair
Amitabh V. Nimonkar et al.
GENES & DEVELOPMENT (2011)
Guidelines for Assessment of Bone Microstructure in Rodents Using Micro-Computed Tomography
Mary L. Bouxsein et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies
Ting-Chao Chou
PHARMACOLOGICAL REVIEWS (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Human Claspin works with BRCA1 to both positively and negatively regulate cell proliferation
SY Lin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Human claspin is required for replication checkpoint control
C Christiano et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
分享论文
